ClinicalTrials.govpublic full text
TMP001 in Relapsing-remitting Multiple Sclerosis
remitting-relapsing multiple sclerosis, multiple sclerosis, relapsing remitting, nonsteroidal anti-inflammatory drug, contrast enhancing lesions, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 848192
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.